MED
Medifast Inc
Price:
14.68
USD
Volume:
153,664
United States | Personal Products
Medifast DCF Valuation - Growth Exit 5Y
76.6 %
Upside
What is the DCF valuation of Medifast?
The Discounted Cash Flow (DCF) valuation of Medifast Inc (MED) is 25.92 USD. With the latest stock price at 14.68 USD, the upside of Medifast Inc based on DCF is 76.6%.
Is Medifast a buy or a sell?
Based on the latest price of 14.68 USD and our DCF valuation, Medifast Inc (MED) is a buy. Buying Medifast stocks now will result in a potential gain of 76.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.0% | 6.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 20.99 - 39.85 | 25.92 |
| Upside | 43.0% - 171.5% | 76.6% |
14.68 USD
Stock Price
25.92 USD
Fair Price
| (USD in millions) | Projections | |||||
| 12-2024 | 12-2025 | 12-2026 | 12-2027 | 12-2028 | 12-2029 | |
| Revenue | 602 | 394 | 380 | 387 | 397 | 410 |
| % Growth | 44% | -35% | -4% | 2% | 3% | 3% |
| Cost of goods sold | (158) | (101) | (96) | (95) | (96) | (97) |
| % of Revenue | 26% | 26% | 25% | 25% | 24% | 24% |
| Selling, G&A expenses | (421) | (275) | (265) | (270) | (277) | (286) |
| % of Revenue | 70% | 70% | 70% | 70% | 70% | 70% |
| Research & Development | (5) | (3) | (3) | (3) | (3) | (3) |
| % of Revenue | 1% | 1% | 1% | 1% | 1% | 1% |
| Net interest & other expenses | (16) | (10) | (10) | (10) | (10) | (11) |
| % of Revenue | 3% | 3% | 3% | 3% | 3% | 3% |
| Tax expense | (2) | (1) | (1) | (2) | (2) | (3) |
| Tax rate | 45% | 23% | 23% | 23% | 23% | 23% |
| Net profit | 2 | 3 | 5 | 6 | 8 | 10 |
| % Margin | 0% | 1% | 1% | 2% | 2% | 2% |